Abbott Laboratories has completed its acquisition of Exact Sciences Corporation, with Exact Sciences shareholders receiving $105.00 per share in cash. This transaction represents a significant strategic expansion for Abbott, as Exact Sciences will now operate as a wholly owned subsidiary.
